| [225Ac] Ac-PSMA-617 mutational landscape in circulating tumor DNA (ctDNA): early clinical outcome prediction in metastatic castration-resistant prostate cancer M AMGHAR, T RAUSCH, T HIELSCHER, H OZGUR, M ROSCHER, ... | | |
| 1 Genomic Oncology Area, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO), Granada, Spain 2Hematology Department, Virgen de … R Ríos-Tamayo, CB Lupianez, D Campa, T Hielscher, N Weinhold, ... | | |
| 174P Frequency and prognostic value of circulating tumor cells in cancer of unknown primary M Pouyiourou, S Riethdorf, T Bochtler, C Coith, B Kraft, T Hielscher, ... Annals of Oncology 34, S250-S251, 2023 | | 2023 |
| 535: Small RNA sequencing identifies microRNAs involved in B-cell receptor signaling in chronic lymphocytic leukemia CJ Blume, T Hielscher, A Hotz-Wagenblatt, L Sellner, J Hüllein, T Stolz, ... European Journal of Cancer, S129, 2014 | | 2014 |
| 738P Combined ipilimumab and nivolumab in previously treated patients with cancer of unknown primary: Results of the CheCUP trial M Pouyiourou, B Kraft, T Wohlfromm, M Stahl, B Kubuschok, H Löffler, ... Annals of Oncology 33, S881, 2022 | 1 | 2022 |
| A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in BRAF-Driven Pediatric Low-Grade … D Usta, R Sigaud, JL Buhl, F Selt, V Marquardt, D Pauck, J Jansen, ... Molecular cancer therapeutics 19 (8), 1736-1750, 2020 | 17 | 2020 |
| A Clinically Usable Gene Expression Report for Risk Assessment and Identification of Possible Therapeutic Targets in Multiple Myeloma. T Meiβner, A Seckinger, T Hielscher, T Rème, J Moreaux, A Benner, ... Blood, The Journal of the American Society of Hematology 114 (22), 1829-1829, 2009 | | 2009 |
| A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis R Ríos-Tamayo, CB Lupiañez, D Campa, T Hielscher, N Weinhold, ... Oncotarget 7 (37), 59029, 2016 | 21 | 2016 |
| A Gene Expression Based Proliferation Index as Independent Prognostic Factor in Multiple Myeloma. D Hose, T Rème, T Hielscher, J Moreaux, T Meißner, A Seckinger, ... Blood 112 (11), 1667, 2008 | 1 | 2008 |
| A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma EK Mai, T Hielscher, JK Kloth, M Merz, S Shah, MS Raab, M Hillengass, ... Haematologica 100 (6), 818, 2015 | 57 | 2015 |
| A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat T Milde, S Kleber, A Korshunov, H Witt, T Hielscher, P Koch, HG Kopp, ... Acta neuropathologica 122, 637-650, 2011 | 98 | 2011 |
| A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma OT Alhalabi, MNC Fletcher, T Hielscher, T Kessler, T Lokumcu, ... Neuro-Oncology 24 (1), 39-51, 2022 | 26 | 2022 |
| A Phase II" open", non-randomized multicenter Study to evaluate the Efficacy and Safety of Nivolumab plus Ipilimumab in Patients with Cancer of unknown Primary Origin and … M Pouyiourou, B Kraft, T Wohlfromm, M Stahl, B Kubuschok, H Loeffler, ... ONCOLOGY RESEARCH AND TREATMENT 45 (SUPPL 2), 163-163, 2022 | | 2022 |
| A PRDX1‐p38α heterodimer amplifies MET‐driven invasion of IDH‐wildtype and IDH‐mutant gliomas P Wirthschaft, J Bode, AEM Simon, E Hoffmann, R van Laack, T Krüwel, ... International journal of cancer 143 (5), 1176-1187, 2018 | 15 | 2018 |
| A Predictive Score for Early Mortality during Induction Therapy in Newly Diagnosed Transplant-Eligible Multiple Myeloma-an Analysis from Five GMMG and HOVON Multicenter Phase … EK Mai, T Hielscher, U Bertsch, J Schlenzka, HJ Salwender, HM Lokhorst, ... Blood 130, 2016, 2017 | | 2017 |
| A robust alternative to the Schemper–Henderson estimator of prediction error M Schmid, T Hielscher, T Augustin, O Gefeller Biometrics 67 (2), 524-535, 2011 | 26 | 2011 |
| A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR R Claus, S Wilop, T Hielscher, M Sonnet, E Dahl, O Galm, E Jost, C Plass Epigenetics 7 (7), 772-780, 2012 | 83 | 2012 |
| A018 Whole-Body MRI in Asymptomatic Plasma Cell Disease J Hillengass, K Fechtner, C Heiss, T Hielscher, K Neben, S Delorme, ... Clinical Lymphoma & Myeloma, S6, 2009 | | 2009 |
| Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma AM Dubuc, M Remke, A Korshunov, PA Northcott, SH Zhan, ... Acta neuropathologica 125, 373-384, 2013 | 191 | 2013 |
| Abstract A14: Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer A Ward, A Balwierz, JD Zhang, M Kueblbeck, S Wiemann, T Hielscher, ... Clinical Cancer Research 18 (10_Supplement), A14-A14, 2012 | | 2012 |
